Interest: The National Science Foundation (NSF) is America’s biggest seed-stage investor. And one of NSF’s portfolio managers has keen insights on what separates the start-up winners from the pack.
Interest: ANN ARBOR, Mich.—Sixteen student teams from six universities across Michigan will present their green technology solutions and vie for more than $100,000 in prizes at the Michigan Clean Energy Venture Challenge next week.
Interest: Mayor Svante Myrick and Cornell University President David Skorton, among others, gathered Thursday afternoon to welcome Glycobia Inc. to the Kevin McGovern Family Center for Venture Development in the Life Sciences in Weill Hall on campus. Glycobia is the first company housed in the center, and immediately represents the important role the center can play in the Ithaca area, Director Lou Walcer said.
Interest: The 6,700-square-foot center is the first lab facility at Cornell University for life sciences start-ups. The center is expected to house from four to six tenants at a time, with the focus on bringing companies from the lab to the marketplace.
Interest: It’s a big number that tends to garner little attention as analysts point to the region’s more imposing accomplishments – the Medical Center, the Houston Port, the energy sector
Interest: Several companies would like to commercialize the fish feed additive the University of Idaho's Aquaculture Research Institute developed to protect trout in the early stages of their life from cold water disease.
Interest: A state-funded research collaboration between Mayo and the U of M, new drugs to fight fungal infections are needed "as the numbers of immuno-compromised patients rise due to HIV, organ transplants, and cancer chemotherapy treatments."
Interest: Let’s face some cold, hard facts.
Banks still aren’t lending much money, and venture capital cash, while spread more liberally in 2011 than in previous years, is still largely hard to come by.
Interest: Today Ford Motor announced it would open a research lab in the San Francisco Bay Area, as part of the Ford Research and Innovation division. The lab will have a broad agenda, from clean drive systems to in-car connected services. Partnerships with app developers will also likely be a major task for the lab, as Ford has just begun to offer app integration in Sync.
Interest: A report released by University of Idaho researchers Thursday shows farm cash receipts for 2011 are projected at $7.4 billion, which is a 29 percent increase compared with 2010, when farm cash receipts increased by 12 percent compared to 2009.
Interest: Biogen and Isis agreed to collaborate to advance an experimental drug that Isis has identified for treating spinal muscular atrophy, a rare genetic disease that causes severe muscle atrophy and weakness in newborns. The deal could eventually be worth as much as $299 million for Isis.
Interest: At the world’s largest consumer electronics tradeshow in Las Vegas, Nevada this year, 2012 CES®, a new TechZone–an assemblage of technology markets grouped together–will be unveiled. Called Eureka Park, the TechZone will feature start-up companies and technologies that are only now emerging from research and development supported by the National Science Foundation (NSF) and various start-up companies.
Interest: This is the latest installment of a new CAP series called “Big Ideas for Small Business.” The weekly series aims to offer a collection of bold proposals that taken together will form a progressive pro-business agenda for the small- and medium-sized companies—and future big companies—our economic competitiveness depends on.
Interest: Andrew Lee hopes to someday make that list.
The 28-year-old co-founder of Stem Cell Theranostics is one of the latest young entrepreneurs to go through StartX, the incubator launched at Stanford last year.
Interest: The Flaum Eye Institute (FEI) at the University of Rochester Medical Center (URMC) has launched a new initiative, called the Excubator, to accelerate the development and commercialization of new technologies. This innovative approach builds upon the region’s history of innovation in eye care, optics, software, and engineering to launch a new generation of technologies to treat diseases of the eye.
Interest: Fashion-forward friends Neil Blumenthal, David Gilboa, Andrew Hunt and Jeffrey Raider aren't your bargain-basement eyewear types. The four University of Pennsylvania Wharton School of business alumni always preferred designer frames and lenses that ran about $500 per pair--a fact they lamented.
Interest: HistoRx licensed a biomarker-based prognostic melanoma assay from Yale University. It is designed to predict which patients with stage II, node-negative disease have an increased risk of disease recurrence. The assay is based on an automated, quantitative IHC technology called Aqua, which was developed by Yale researchers and which HistoRx is exploiting to develop a range of diagnostics.
My profile
Loading...
